Background: Overweight and obesity are significant public health concerns that are prevalent in younger age cohorts. Preventive or therapeutic interventions are difficult to implement and maintain over time. On the other hand, the majority of adolescents in the United States have a smartphone, representing a huge potential for innovative digitized interventions, such as weight loss programs delivered via smartphone applications. Although the number of available smartphone applications is increasing, evidence for their effectiveness in weight loss is insufficient. Therefore, the proposed study aims to assess the efficacy of a gamification-based smartphone application for weight loss in overweight and obese adolescents. The trial is designed to be a phase II, single-centre, two-arm, triple-blinded, randomized controlled trial (RCT) with a duration of 6 months. Method: The intervention consists of a smartphone application that provides both tracking and gamification elements, while the control arm consists of an identically designed application solely with tracking features of health information. The proposed trial will be conducted in an urban primary care clinic of an academic centre in the United States of America, with expertise in the management of overweight and obese adolescents. Eligible adolescents will be followed for 6 months. Changes in body mass index z score from baseline to 6 months will be the primary outcome. Secondary objectives will explore the effects of the gamification-based application on adherence, as well as anthropometric, metabolic and behavioural changes. A required sample size of 108 participants (54 participants per group) was calculated. Discussion: The benefits of the proposed study include mid-term effects in weight reduction for overweight and obese adolescents. The current proposal will contribute to fill a gap in the literature on the mid-term effects of gamification-based interventions to control weight in adolescents. This trial is a well-designed RCT that is in line with the Consolidated Standards of Reporting Trials statement.
Introduction
Obesity in childhood and adolescence is a current public health challenge that is rising worldwide. 1, 2 Although prevalence in adolescents worldwide is uncertain and variable across regions and countries, among adolescents living in the United States (US), aged 12-19 years, obesity has increased from 5% in 1976 to over 18.4% in 2010. These growing rates in the US are even more profound in Black and Latino groups, exceeding 20%. 3 According to the National Health and Nutrition Examination Survey 2009-10 (NHANES) overweight and obesity in this age (12) (13) (14) (15) (16) (17) (18) (19) bears nearly 30% overall, showing also sex, geographic and socioeconomic discrepancies. 4, 5 Studies in paediatric populations have demonstrated the importance of lifestyle programs on the management of obesity, and its relation to self-learning of healthy habits, self-monitoring of food intake and physical activity, to improve health outcomes. 6, 7 However, treatments in this age group face difficulties such as high attrition, poor adherence, and complex programs, limiting the efficacy of weight control treatments. 8, 9 In the US, 78% of teenagers have a smartphone, demonstrating a huge potential for digitized cardiovascular prevention and health promotion in the youth. 10 Studies show that technology-based interventions on weight loss and quality of life for patients suffering from overweight or obesity are more efficient than standard care in the short term. 11 The use of mobile applications can be beneficial in monitoring patients' health behaviour, chronic disease symptoms, promoting medication adherence and raising self-awareness. 12 Mobile and multimedia technologies also show a promising opportunity to enhance healthcare knowledge, health promotion and disease prevention. Systematic reviews show that technology-based interventions might be valid tools for weight loss, leading to higher program adherence and improved monitoring. [12] [13] [14] Furthermore, smartphone applications may represent an option to improve health habits, and to motivate for physical activity and weight loss using gamification. 15, 16 A systematic review of game-based interventions in rehabilitation of diabetic patients showed a significant effect on health-related quality of life, balance, and strength, although there was no effect on glycated haemoglobin. 17 Although many mobile applications claim to improve health outcomes, such as supporting weight loss, efficacy evidence and gamification methodological quality is insufficient. 12, 14, [17] [18] [19] Other groups underline the need for full-scale summative evaluation studies of existing games. 20 Despite the increasing interest in studying technology-based tools to prevent or manage obesity and overweight in adolescent, a lack of trials, small sample sizes and mixed results are still hampering a more standardized and evidence-based approach to this target population. 21 Additionally, trials using standardized evaluations are limited and mostly focus on adult populations. 22 Therefore, this study aims to assess the efficacy of a gamification-based smartphone application for weight loss in overweight and obese adolescents using a single-centre, two-arm, triple-blinded, phase II randomized controlled trial (RCT). The application combines tracking (monitoring) and gamification to develop a healthy lifestyle and can be a tool in the management of obesity in children and teenagers. In this trial protocol, a hypothetical smartphone application is considered.
Methods

Trial design
The trial will be a phase II, single-centre, twoarm, triple-blinded, RCT with a duration of 6 months. The proposed trial protocol was developed to answer the following research question: does a 6-month intervention, based on the use of a gamification-based smartphone application, on top of standard care, help overweight and obese adolescents to lose weight, in comparison with the combination of a passive tracking application and standard care alone? Figure 1 
Study setting
The trial will be conducted in an urban primary care clinic of an academic centre in the USA, with expertise in the management of overweight and obese adolescents.
Eligibility criteria
Patients who fulfill the following inclusion criteria will be eligible to be enrolled in the study: Patients fulfilling any of the following criteria will be excluded from the trial:
• Secondary causes of obesity (e.g. endocrine abnormality) • Chronic diseases such as cardiovascular diseases, renal diseases, liver diseases, obstructive pulmonary diseases, classic symptoms of hyperglycaemia (polyuria, polyphagia, polydipsia and weight loss) • Severe acute illness, children receiving chemotherapy • Patients on pharmacologic intervention for weight reduction, children already participating in weight loss programs or already using lifestyle-targeting application 
Interventions
The intervention consists of a hypothetical smartphone application that provides both tracking and gamification elements, while the control arm consists of an identically designed application with solely tracking features of health information (Fig. 2) .
Eligible patients will be randomized to use a specific smartphone application on top of standard care for a 6-month period. The hypothesis is that specific application features will improve engagement in lifestyle changes towards weight loss. The application uses a personalized approach and involves games and activities to educate children and adolescents about healthy eating and physical activity.
The application comprises tracking and monitoring functions using diaries of food intake (calories consumed each day in each meal), exercises (type and duration) and daily steps. Additionally, elements of gamification, such as challenges and points systems, are used in order to promote healthy nutrition choices and exercises.
Standard care will be left to the attending physician's discretion in consonance with recommendations by 2017 Endocrine Society Clinical Practice Guideline on Paediatric Obesity, 26 in which weight loss medications are not a part of initial management of obesity. 27 Adherence To increase adherence, both the control and intervention arm will receive text messages one week prior to clinic appointments as well as phone contact the day before. Centers will provide an opportunity to reschedule missed appointments within 1 week.
A 1-month run-in period will be used to evaluate participants' motivation and to educate participants on how to use the basic smartphone application (without gamification features), prior to randomization.
Process evaluation, as a part of the secondary analysis, will be measured to assess adherence of included participants. Interactions with the application (utilization) per week, time using the application and number of attendance to appointments will be recorded.
Timeline
After study enrollment, the eligibility criteria will be assessed for each participant according to the baseline clinical assessment in the first visit (Fig. 3) . Written informed assent and consent will be taken from all participants and their parents or legal guardian, respectively.
Participants will be followed up for 6 months. Data for the primary outcome will be assessed at baseline and after 6 months while data for secondary outcomes will be collected monthly.
Randomization
Patients will be randomized to either the experimental or control arm with a 1:1 allocation ratio, through an online central randomization service. The randomization process will use permuted blocks of four, stratified according to school, in order to prevent covariate imbalances between groups. Allocation concealment will be ensured, as the service will not release the randomization code until the end of the trial. Access to the application will be given by independent access personnel. Throughout the study, the randomization will be conducted by the independent service account for blinding of data manager and statistician.
Blinding
The study will be designed as a triple-blinded trial. Participants, treating physicians and dietitians, as well as outcome evaluators and data analysts will be blinded.
Participants in both arms will receive standard care and access to a smartphone application that will be identical in terms of interface style and design. Care providers will participate in an intense training program before entering the study. Independent research personnel, not involved in patient care, will give access to the application to each participant. Blinding will be supported by the similarities of the smartphone application versions used for the intervention group and the control groups in terms of design and function.
To evaluate the robustness of blinding, participants will be asked after the trial ends to which group they anticipate they were initially assigned to.
Sample size calculation
In the light of observational study results, an expert panel of the US Preventive Services Task Force recommends a BMI z score reduction in the range of 0.20 to 0.25 to be a suitable threshold for clinically important changes. 28 Considering a clinically meaningful difference of 0.25, power of 80%, α-level of 0.05, and a potential dropout rate of 20%, obtained from previous trials of similar methodology, 29,30 a required sample size of 108 participants (54 participants per group) was calculated.
Recruitment
Recruitment will be based on two parallel strategies. Advertising in schools belonging to the district of the relevant primary care center will be conducted using posters, leaflets and a webpage. Additionally, teachers from the schools situated in the relevant districts will be involved.
In addition to school-based advertisements, the primary care center itself will be involved using posters, leaflets and a webpage. Practitioners and health staff will be motivated to approach patients during routine appointments.
Primary objective
The primary objective will be to determine if the gamification-based intervention delivered via a smartphone application plus standard care is superior to standard care combined with a tracking application in reducing BMI z score (as a measure adjusted for age and sex) from baseline to 6 months.
Secondary objectives
Measurements for secondary objectives will explore the effects of the gamification-based application on adherence, as well as on anthropometric, metabolic and behavioural changes. Including aspects derived from the Health Action Process Approach by Schwarzer and Fuchs will increase the understanding of the behaviour change process. 31 In addition to the primary measurement, BMI z score will also be evaluated monthly to support understanding of behaviour change. Monthly anthropometric changes in the body shape index (ABSI, waist circumference normalized to height and weight) will also be verified. To assess cardiovascular risk factors, blood pressure, lipids and glycaemic status (fasting plasma glucose, glycated haemoglobin, insulin) will be evaluated at baseline and after 6 months.
On top of that, steps will be counted by a builtin feature of the application and a physical activity questionnaire for adolescents (PAQ-A) will be applied. This information will allow for classifying adolescents into different physical activity clusters and will help to investigate the connection between physical activity, health behaviour and health-related outcomes. 32 Measurements of service utilization will be performed at baseline as well as after 3 and 6 months to support the understanding of the behaviour change process.
Readiness to change lifestyle, self-efficacy ('generalized self-efficacy scale') and quality of life ['impact of weight on quality of life-kids' (IWQOL-Kids)] will be measured. The IWQOL is a 27-item, self-administered, brief (taking around 8 min) and weight-related measure to assess quality of life in adolescents. 33 Selfefficacy is seen as an indicator for coping strategies and confidence in weight loss treatments. 34 The generalized self-efficacy scale developed by Schwarzer and colleagues will be applied. 35 It will be enriched by using dimensions of accurate measurements appropriate for the target group in terms of age, sex and ethnic differences to cover specific elements of physical exercise self-efficacy. 36, 37 Adherence will also be analyzed by evaluating the self-reported frequency of application utilization and its most relevant features using a structured questionnaire.
Statistical analysis
The primary and secondary outcomes will be analyzed and compared between the two study groups. Distribution of data will be analyzed by visual (histograms and SD) and statistical normality tests (Shapiro-Wilk).
Changes in BMI z score from baseline to 6 months will be compared using an unpaired t test (Table 1 ). In the analysis of secondary outcomes, continuous variables will be analyzed with an unpaired t test, ordinal data will be analyzed using a Mann-Whitney U test and, for categorical variables, Fisher's exact test or Chi-square test will be applied (Table 1 ).
Analysis and reporting will be in line with the Consolidated Standards of Reporting Trials (CONSORT) guidelines for reporting parallel group RCTs. 38 No interim analysis will be performed.
Missing data Data will be analyzed on an intention to treat basis. Missing data will be handled through multiple imputation. A sensitivity analysis will be carried out considering a worst-case scenario (i.e. patients did not lose any weight during the trial).
Data management
Patient data and profiles will be protected with an individual code only the principal investigator will have access to. The patient's profiles and collected data will be stored on secure servers using only password-protected computers, only available for personnel approved by the Institutional Review Board (IRB). No formal data monitoring committee will be installed as there is no safety concern.
Withdrawal and stopping rules
Patients will be free to withdraw from the study whenever they want. If they decide to withdraw, they will be asked to attend the follow-up measurement after month 6 and provide data. No further data will be collected if participants refuse to attend the follow-up measurement or refuse to provide data.
No stopping rules will be defined, as the intervention will not ask adolescents to do anything beyond standard care and using a smartphone application providing tracking (physical activity and diet) and gamification. Nevertheless, all adverse events will be documented and evaluated in terms of causality.
Discussion
The main aim of the proposed RCT is to assess the efficacy of a smartphone application with a gamification approach for healthy lifestyle promotion, to help overweight and obese adolescents to reduce weight. The hypothetical smartphone health application is designed specifically for children and teenagers, to help in self-monitoring of food habits and physical activity in order to develop a healthy lifestyle. Benefits of the proposed study include the evaluation of mid-term effects in weight reduction for overweight and obese adolescents, which is also relevant for future trial protocols.
A recent systematic review on the evaluation of smartphone applications for health behaviour change summarized that no single best practice approach can be suggested to evaluate mobile health apps due to insufficient data, leading to potentially incomplete and inaccurate guidance. 39 As reported by Neugebauer and colleagues there are specific barriers to the conduct of RCTs on medical devices including matters of trial design, such as randomization, acceptability, blinding, determining appropriate outcomes. 40 Accordingly, the study group carefully designed the proposed trial aiming to minimize the risk of bias.
The current study will address multiple gaps in the literature, such as missing data on the midterm effects of smartphone interventions. The efficacy of innovative treatment strategies, like gamification, will be analyzed due to their current heterogeneity in terms of contents and methodologies of interventions and studies. 41 Due to their potential to improve the reach and access to target populations, the trial uses a smartphone application. 42 However, to this day there is no clear understanding of the processes through which such applications work. 43 It is a huge challenge for study designs to investigate these combined mechanisms singularly. In the proposed study protocol this challenge is addressed by the introduction of a passive application that enables a more specified investigation of the active treatment.
Due to the repetitive nature of games (e.g. video games), the potential of promoting health-related learning can be of special benefit for children. 44, 45 The suggested application combines multiple components including monitoring, tracking and gamification. The proposed protocol will provide further knowledge on the efficacy of combining functionalities within one intervention in overweight and obese children.
Although designed as a triple-blinded RCT, unblinding will be a serious threat in this trial. Participants may guess that they are in the control arm when talking to other participants of the study. However, the study group addressed this challenge by introducing a sham-like application in the control arm that will have an identical design as the smartphone application used in the intervention group, in order to lower the risk of dropout and un-blinding. Similarly, low adherence may hamper the study feasibility. However, the study group will address this issue in multiple ways, such as establishing multiple application features, structured reminders for appointments and the fact that the intervention is accessible on a 24-hour basis. Maintenance of blinding and concealment is also supported by separating randomization from the treating professionals and restricting the access to the randomization code until the end of the project.
A 6-month follow-up protocol will be chosen, assuming this is a reasonable period to detect meaningful changes in BMI z score. Indeed, this is the duration frequently used in studies investigating behaviour changes. 46, 47 However, the effects of the intervention may not be sustained over time. In this regard, monthly measurements, as well as information on application usage and self-reported feedback by the participants will allow developing a deeper understanding of progressive effects of the intervention up to 6 months.
A recent review on the effect of smartphone applications on glycaemic control improvement summarized that the functionality and application of the technology require standardization. The authors also call for policy and guidance. 48 The developed trial protocol has the potential to provide such guidance by presenting a highquality approach to test technological solutions for specific target groups, such as overweight and obese adolescents, which allows gaining a deeper understanding for these emerging technologies and their possible benefits for specific populations.
The developed framework of this protocol is in line with the CONSORT statement 38 and provides new strategies of dealing with smartphone applications in clinical research. The proposed study protocol can be used by other groups that aim to generate efficacy data evaluating smartphone applications for the management of obesity and other chronic metabolic conditions in adolescents.
In conclusion, this protocol intends to evaluate an innovative, cheap, increasingly popular intervention (smartphone application) aimed to help control a relevant condition, that is, obesity in the young, focussing on a specific, novel aspect of mobile interventions (gamification). The proposal is a well-designed RCT based on standardized, robust procedures and following the most rigorous requirements in scientific investigation.
Trial status
At the time of submission, the trial was at the planning stage and had not yet started recruiting patients. The protocol will be registered in an online clinical trial database before starting with the trial. The protocol will be presented to an IRB for approval.
The study protocol was developed based on intense discussions of international young scientists taking part in a distance learning program in the field of clinical research. Due to their affiliations in heterogeneous disciplines, the developed study protocol is intended to be a methodological contribution rather than a protocol of a trial that will be effectively conducted by the present group of authors. The results of this proposed trial may provide guidance for clinical practice and this protocol can be used by other groups.
